Project Number 3P50AG025688-14S1 Agency/Funding Organization NIA Funding Year 2018 View Full Project Details for Emory Alzheimers Disease Center Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category F. Research Resources 1. Alzheimer's Disease Centers Researcher and Organization Principal Investigator LEVEY, ALLAN I Principal Investigator First Name ALLAN Principal Investigator Last Name LEVEY Awardee Organization EMORY UNIVERSITY Awardee State Georgia Contact PI Country United States Project Detail Funding Opportunity Announcement PA-18-586: Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed) FY Overall Cost $121,332 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official SILVERBERG, NINA B Related Resources Repository [NIAGADS] ADC3- Alzheimer Disease Center Dataset 3 [NIAGADS] ADGC African American Summary Statistics- Reitz et al. (2013) [NIAGADS] ADGC Neuropath Summary Stats and Phenotypes- Beecham et al. (2014) [NIAGADS] ADGC Summary Statistics- Naj et al. (2011) [NIAGADS] ADC1- Alzheimer Disease Center Dataset 1 [NIAGADS] ADC2- Alzheimer Disease Center Dataset 2 Emory University Alzheimer's Disease Research Center National Alzheimer's Coordinating Center (NACC) [AlzPED] Peripheral administration of the soluble TNF inhibitor XPro1595 modifies brain immune cell profiles, decreases beta-amyloid plaque load, and rescues impaired long-term potentiation in 5xFAD mice [AlzPED] 7,8-dihydroxyflavone prevents synaptic loss and memory deficits in a mouse model of Alzheimer's disease
